Vivek Ramaswamy @VivekGRamaswamy
I remember when we first started developing this therapy in 2016. Many said the patient population was too small,… https://t.co/BM8RYCtLGw — PolitiTweet.org
Dr. Janet Woodcock @DrWoodcockFDA
The development of safe and effective medical products for patients affected by rare diseases is an area of critica… https://t.co/HqlHfb4lBc